First Time Loading...

WuXi AppTec Co Ltd

Watchlist Manager
WuXi AppTec Co Ltd Logo
WuXi AppTec Co Ltd
Price: 86.18 CNY -1.7% Market Closed
Updated: Oct 1, 2023

Intrinsic Value

Intrinsic Value History
WuXi AppTec Co Ltd

Whether you're assessing long-term stability or short-term opportunities, Historical Valuation serves as a vital tool to enhance your investment approach, enabling you to make more informed investment decisions.

This feature available only with
Unlimited Plan

Sign up to access WuXi AppTec Co Ltd's intrinsic value history.

No restrictions, no limits.
All stocks, all tools.

Spot Contrarian Opportunities

Look for stocks that have been historically overvalued but are now trading below their intrinsic value.

Easily Identify Value Traps

Avoid stocks that are always undervalued and never reach their intrinsic value.

Find Strong Rebounds

Find stocks that have historically corrected quickly from being undervalued to reaching their intrinsic value.

Valuation Methods

There are two methods to calculate the Intrinsic Value of a stock: DCF Valuation and Relative Valuation. We take the average of these two methods to estimate the intrinsic value as accurately as possible. You can see the Intrinsic Value of a stock at the top of this page.

DCF Value
Discounted Cash Flow

DCF Parameters:
Operating Model
Discount Rate
Forecast Period
Terminal Growth
DCF Input
DCF Input
DCF Input

Fundamental Analysis


Balance Sheet Decomposition
WuXi AppTec Co Ltd

Current Assets 27.6B
Cash & Short-Term Investments 9.7B
Receivables 10.2B
Other Current Assets 7.7B
Non-Current Assets 41.7B
Long-Term Investments 10.3B
PP&E 25.2B
Intangibles 3.8B
Other Non-Current Assets 2.4B
Current Liabilities 16.4B
Accounts Payable 2B
Accrued Liabilities 2.4B
Short-Term Debt 4B
Other Current Liabilities 7.9B
Non-Current Liabilities 3.1B
Long-Term Debt 1.5B
Other Non-Current Liabilities 1.7B
Fundamental Scores

Profitability Score
Profitability Due Diligence

WuXi AppTec Co Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Positive Revenue Growth Forecast
Positive Operating Income

WuXi AppTec Co Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

WuXi AppTec Co Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Negative Net Debt

WuXi AppTec Co Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
WuXi AppTec Co Ltd

Wall Street analysts forecast WuXi AppTec Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WuXi AppTec Co Ltd is 121.8 CNY with a low forecast of 71.51 CNY and a high forecast of 179.55 CNY.

Price Target
71.51 CNY
17% Downside
Price Target
121.8 CNY
41% Upside
Price Target
179.55 CNY
108% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Return Decomposition
Main factors of price return

What is price return decomposition?

WuXi AppTec Co Ltd

1M 1M
6M 6M
1Y 1Y
3Y 3Y
5Y 5Y
10Y 10Y
Annual Price Range
52w Low
52w High
Price Metrics
Average Annual Return 42.24%
Standard Deviation of Annual Returns 62.54%
Max Drawdown -63%
Shares Statistics
Market Capitalization 256B CNY
Shares Outstanding 2 941 172 868
Percentage of Shares Shorted

Company Profile

WuXi AppTec Co Ltd Logo
WuXi AppTec Co Ltd




Life Sciences Tools & Services

Market Cap

256B CNY

Dividend Yield



WuXi AppTec Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Shanghai, Shanghai and currently employs 34,912 full-time employees. The company went IPO on 2018-05-08. WuXi AppTec Co., Ltd. is a China-based investment holding company principally engaged in the provision of new drug research and development (R&D), production and supporting services, as well as related technology platform services. The firm is mainly engaged in the discovery, development and production of small molecule drugs, cell therapies and gene therapies, as well as providing testing services for medical devices. The firm mainly conducts its businesses through four segments, including China-based Laboratory Services segment, Contract Manufacturing organization/contract development and manufacturing organization services (CMO/CDMO services) segment, US-based Laboratory Services segment and Clinical Research segment.


No. 288 Fute Middle Road, Waigaoqiao Free Trade Zone, Pudong New Area




34 912


Co-Founder, Chairman, Pres & CEO
Dr. Ge Li Ph.D.
Co-Chief Exec. Officer & Exec. Director
Dr. Minzhang Chen Ph.D.
Co-CEO & Exec. Director
Dr. Qing Yang Ph.D.
Vice Chairman & Global Chief Investment Officer
Dr. Edward Hu M.B.A.
Sr. VP & CFO
Ms. Ming Shi
Chief Scientific Officer & Exec. VP
Dr. Shuhui Chen Ph.D.
Show More
IR Director
Mr. Kyler Lei
Joint Company Sec. & Exec. Director of the Corp. Legal Office
Mr. Yao Chi
Sr. VP, Gen. Counsel & Global Head of HR
Dr. Howard Wu J.D.
COO of China, Exec. VP & Director
Mr. Zhaohui Zhang
Show Less

See Also

Other Stocks
What is the Intrinsic Value of one WuXi AppTec Co Ltd stock?

The intrinsic value of one WuXi AppTec Co Ltd stock under the Base Case scenario is 154.71 CNY.

Is WuXi AppTec Co Ltd stock undervalued or overvalued?

Compared to the current market price of 86.18 CNY, WuXi AppTec Co Ltd is Undervalued by 44%.